Alternance 12 mois – Apprenti(e) Solutions Marketing B2B et stratégie commerciale Obésité – F/H

Neuilly-sur-Seine, Ile-de-France, France

Apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, MarketingIndustries

Requirements

The ideal candidate should be a pharmacist with a specialization in business/marketing, and ideally possess prior experience in the pharmaceutical industry or in pharmacies. They should be autonomous, invested, and rigorous, demonstrating initiative, creativity, analytical skills, and strong interpersonal abilities. Furthermore, they should have a good command of English and proficiency in computer tools, along with a genuine interest in digital technologies.

Responsibilities

As an apprentice, the Solutions Marketing B2B and commercial strategy trainee will develop, design, and monitor the deployment of tools and solutions supporting the strategy and partnerships with pharmacies, in collaboration with marketing and medical teams. They will also define and elaborate a mapping of key actors in the product journey (pharmacies, pharmacy groups, central pharmacies, other private structures) to identify priority partnership opportunities, measure and pilot the performance and impact of partnership actions and commercial policies, participate in tactical and strategic thinking phases regarding the product and patient care journey, and conduct competitive monitoring.

Skills

Marketing

B2B

Commercial Strategy

Pharmacy

Analytical Skills

Interpersonal Skills

English

Digital Technologies

Mapping

Performance Measurement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free